Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;36(4):154-161.
doi: 10.1089/jamp.2022.0057. Epub 2023 May 30.

Multidrug Aerosol Delivery During Mechanical Ventilation

Affiliations

Multidrug Aerosol Delivery During Mechanical Ventilation

Ann D Cuccia et al. J Aerosol Med Pulm Drug Deliv. 2023 Aug.

Abstract

Background: In the critically ill, pulmonary vasodilators are often provided off label to intubated patients using continuous nebulization. If additional aerosol therapies such as bronchodilators or antibiotics are needed, vasodilator therapy may be interrupted. This study assesses aerosol systems designed for simultaneous delivery of two aerosols using continuous nebulization and bolus injection without interruption or circuit disconnection. Methods: One i-AIRE dual-port breath-enhanced jet nebulizer (BEJN) or two Aerogen® Solo vibrating mesh nebulizers (VMNs) were installed on the dry side of the humidifier. VMN were stacked; one for infusion and the second for bolus drug delivery. The BEJN was powered by air at 3.5 L/min, 50 psig. Radiolabeled saline was infused at 5 and 10 mL/h with radiolabeled 3 and 6 mL bolus injections at 30 and 120 minutes, respectively. Two adult breathing patterns (duty cycle 0.13 and 0.34) were tested with an infusion time of 4 hours. Inhaled mass (IM) expressed as % of initial syringe activity (IM%/min) was monitored in real time with a ratemeter. All delivered radioaerosol was collected on a filter at the airway opening. Transients in aerosol delivery were measured by calibrated ratemeter. Results: IM%/h during continuous infusion was linear and predictable, mean ± standard deviation (SD): 2.12 ± 1.45%/h, 2.47 ± 0.863%/h for BEJN and VMN, respectively. BEJN functioned without incident. VMN continuous aerosol delivery stopped spontaneously in 3 of 8 runs (38%); bolus delivery stopped spontaneously in 3 of 16 runs (19%). Tapping restarted VMN function during continuous and bolus delivery runs. Bolus delivery IM% (mean ± SD): 20.90% ± 7.01%, 30.40% ± 11.10% for BEJN and VMN, respectively. Conclusion: Simultaneous continuous and bolus nebulization without circuit disconnection is possible for both jet and mesh technology. Monitoring of VMN devices may be necessary in case of spontaneous interruption of nebulization.

Keywords: administration; aerosols; drug delivery; inhalation; mechanical; nebulizers and vaporizers; ventilators.

PubMed Disclaimer

Conflict of interest statement

The State University at Stony Brook holds patents in the fields of nebulizer development and inhaled drug delivery, which have been licensed to InspiRx. G.C.S. is a consultant to InspiRx and is a member of the Advisory Board; A.D.C. serves as a consultant to InspiRx, Inc.; M.M. and J.A.L. have no conflicts.

Figures

FIG. 1.
FIG. 1.
Experimental setup: The ventilator circuit during continuous infusion with the i-AIRE BEJN prototype with dual-medication port adaptor. BEJN, breath-enhanced jet nebulizer.
FIG. 2.
FIG. 2.
Stacked Aerogen Solo VMN and two controllers. One VMN and controller designated for continuous infusion (left) and designated bolus VMN and controller (right). VMN, vibrating mesh nebulizer.
FIG. 3.
FIG. 3.
i-AIRE BEJN prototype with dual-medication port adaptor. Continuous infusion line is screwed on to nebulizer port with leur lock cap outfitted with medication port equipped with tethered cap and plug. Both nebulizer ports empty into a single nebulizer bowl.
FIG. 4.
FIG. 4.
Depicts i-AIRE BEJN at 5 mL/h and DC 0.13, including slopes and quantification of contribution of continuous infusion used for calculation of IM% from bolus syringe deposited on filter. Vertical axis: IM%, expressed as a % of initial syringe charge; Horizontal Axis: run time (minutes). DC, duty cycle; IM, inhaled mass.
FIG. 5.
FIG. 5.
i-AIRE BEJN (■) and Aerogen Solo VMN (•) during continuous infusion at 5 mL/h and DC 0.13. Three milliliters bolus injected into nebulizer at 30 minutes, 6 mL bolus added at 120 minutes. IM filter changed at 90 and 160 minutes. Aerogen Solo VMN: 6 mL bolus nebulizer spontaneously stopped at 125 minutes, tapped and restarted at 135 minutes with bolus consumed by 145 minutes. IM filter changed at 90 and 160 minutes. Vertical Axis: IM%, expressed as a % of initial syringe charge; horizontal axis: run time (minutes).

References

    1. Elnadoury O, Beattie J, Lubinsky AS. Uninterrupted continuous and intermittent nebulizer therapy in a COVID-19 patient using sequential vibratory mesh nebulizers: a case report. J Aerosol Med Pulm Drug Deliv 2020;33(6):357–360. - PubMed
    1. Hill NS, Preston IR, Roberts KE. Inhaled therapies for pulmonary hypertension. Respir Care 2015;60(6):794–805. - PubMed
    1. Torbic H, Szumita PM, Anger KE, et al. . Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. J Crit Care 2013;28(5):844–848. - PubMed
    1. Haché M, Denault A, Bélisle S, et al. . Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery. J Thorac Cardiovasc Surg 2003;125(3):642–649. - PubMed
    1. Sonti R, Pike CW, Cobb N. Responsiveness of inhaled epoprostenol in respiratory failure due to COVID-19. J Intensive Care Med 2021;36(3):327–333. - PMC - PubMed